mci 9038 has been researched along with Ache in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bartholomew, J; Berkowitz, SD; Fareed, J; Hursting, MJ; Jang, IK; Kelton, JG; Lerner, RG; Lewis, BE; Matthai, WH; Moran, J; Rifkin, SD; Rustagi, PK; Sham, R; Walenga, JM; Wallis, DE; Zeigler, ZR | 1 |
| Fujii, K; Kanno, Y; Konishi, K; Ohgou, N | 1 |
2 trial(s) available for mci 9038 and Ache
| Article | Year |
|---|---|
Argatroban anticoagulant therapy in patients with heparin-induced thrombocytopenia.
Topics: Aged; Anticoagulants; Arginine; Blood Coagulation; Blood Coagulation Tests; Diarrhea; Exanthema; Female; Hemorrhage; Heparin; Humans; Male; Middle Aged; Pain; Pipecolic Acids; Purpura; Sulfonamides; Thrombocytopenia; Treatment Outcome | 2001 |
A specific thrombin inhibitor, argatroban, alleviates herpes zoster-associated pain.
Topics: Aged; Antithrombin III; Antithrombins; Arginine; Female; Herpes Zoster; Humans; Immunohistochemistry; Male; Middle Aged; Pain; Pain Measurement; Peptide Hydrolases; Pipecolic Acids; Prospective Studies; Prothrombin; Statistics, Nonparametric; Sulfonamides; Treatment Outcome; Up-Regulation | 2001 |